Skip to main content

Zinc

Zinc is an essential trace element that serves as a cofactor for > 300 enzymes and is required by > 3,000 transcription factors, making it critical for DNA synthesis, protein folding, immune function, wound healing, and cell division.[1][2] An estimated 17% of the global population is at risk for zinc deficiency, with prevalence rising to 35–45% among older adults in the US.[3][4]

For the reconstructive urologist and urogynecologist, zinc matters in four high-yield ways: (1) wound healing — zinc is a cofactor for the matrix-metalloproteinases and collagen-synthesizing enzymes active in the proliferation phase, and topical zinc oxide / Unna-boot dressings are workhorses in pelvic / perineal wound care; (2) the long-term zinc user with neurogenic-bladder presentation — chronic zinc excess (oral supplements, denture-adhesive creams) causes copper deficiency myelopathy that mimics B12-related subacute combined degeneration; (3) post-bariatric trace-element surveillance; and (4) cirrhotic patients facing major reconstruction (84–96% deficiency prevalence; HE-modifying treatment evidence).

Biochemistry and Homeostasis​

The adult body contains approximately 2–3 g of zinc: 85% in muscle and bone, 11% in skin and liver, only ~ 0.1% in plasma.[4][5] In plasma, zinc is ~ 60% bound to albumin (making hypoalbuminemia a major confounder of serum zinc measurement) and the remainder to α2-macroglobulin.[4][6] Zinc fulfills three primary biological roles:[2]

  • Catalytic — Cofactor for enzymes including carbonic anhydrase, alkaline phosphatase, carboxypeptidases, and matrix metalloproteinases (critical for wound healing and tissue remodeling).[2][7]
  • Structural — Zinc finger motifs stabilize the tertiary structure of transcription factors, nuclear receptors, and DNA-repair / signaling proteins.[2][3]
  • Regulatory — Modulates gene expression, apoptosis, cytokine production, and intracellular signaling cascades including NF-κB.[1][2]

Unlike iron, the body has no specialized zinc storage mechanism, necessitating regular dietary intake. Homeostasis is maintained primarily by adjusting intestinal absorption (in the jejunum) and endogenous fecal excretion from pancreatic and intestinal secretions.[5][8]

Dietary Sources and Requirements​

Zinc is found predominantly in animal-source foods — red meat, shellfish (especially oysters), poultry, dairy, eggs — as well as legumes, nuts, and fortified cereals.[8][4] The US RDA is 8 mg/day for women and 11 mg/day for men, with the UL set at 40 mg/day.[8][9] Bioavailability is significantly affected by phytate (whole grains, legumes, seeds), which chelates zinc and inhibits absorption — a key concern for vegetarian / vegan diets.[10][11]

Assessment of Zinc Status​

Serum / plasma zinc concentration is the best available biomarker for population-level assessment, with important limitations:[12][5][6]

  • Normal range ~ 80–100 μg/dL in healthy adults; < 70 μg/dL is the established cutoff for severe deficiency under standardized experimental restriction and in acrodermatitis enteropathica.[13][14]
  • Sex- and time-of-day-specific cutoffs (men < 72 μg/dL, women < 68 μg/dL morning fasting; lower thresholds for afternoon draws) are used in IZiNCG / BOND frameworks.
  • Confounders: hypoalbuminemia (OR 11.2 for low zinc), pregnancy (OR 9.6), anemia in females (OR 3.4), inflammation, afternoon / evening blood draws (5–15% lower than morning fasting), and recent meals.[15][6]
  • Serum zinc does not correlate with dietary or supplemental zinc intake in NHANES data, reflecting tight homeostatic regulation.[6]
  • No reliable biomarker exists for mild-to-moderate zinc deficiency in individuals; growth response to supplementation remains the best functional indicator in children.[12][5]

Causes of Deficiency​

CategoryExamples
Dietary insufficiencyVegan / vegetarian diets (high phytate), poverty, alcohol use disorder, elderly with poor intake
MalabsorptionCeliac disease, IBD, short bowel syndrome, chronic diarrhea, pancreatic insufficiency
Increased lossesCirrhosis (urinary excretion), burns, chronic renal disease, diarrheal illness
Increased demandPregnancy, lactation, rapid growth (infancy / adolescence)
GeneticAcrodermatitis enteropathica (SLC39A4 mutations)
MedicationsPenicillamine, diuretics, iron supplements (competitive absorption)
Liver diseaseCirrhosis (prevalence 84–96%), ALD, MASLD, viral hepatitis

Clinical Manifestations of Deficiency​

The clinical spectrum ranges from subtle, nonspecific symptoms in mild deficiency to life-threatening disease in severe cases:[16][17][18]

  • Mild — Oligospermia, slight weight loss, hyperammonemia, impaired taste acuity, poor appetite.
  • Moderate — Growth retardation, delayed puberty, hypogonadism in males, rough skin, mental lethargy, delayed wound healing, impaired dark adaptation.
  • Severe — Bullous-pustular periorificial and acral dermatitis, alopecia, diarrhea, emotional disturbance, recurrent infections, weight loss — fatal if untreated.

Immune dysfunction is a hallmark of zinc deficiency, affecting both innate immunity (impaired neutrophil chemotaxis, reduced NK-cell activity, decreased phagocytosis) and adaptive immunity (thymic atrophy, lymphopenia, impaired T-cell proliferation, reduced antibody responses).[4]

Acrodermatitis Enteropathica​

Autosomal recessive disorder caused by mutations in the SLC39A4 zinc transporter gene; the prototypical severe zinc-deficiency syndrome. Classic triad: periorificial / acral dermatitis, alopecia, diarrhea, typically presenting in infancy after weaning from breast milk.[19][20] Acquired forms occur with malnutrition, TPN without zinc, and exclusive breastfeeding in premature infants. Treatment with oral zinc (3 mg/kg/day elemental) produces rapid clinical improvement.[20][21]

Clinical Applications of Zinc Supplementation​

The AREDS trial demonstrated that antioxidants + zinc (80 mg zinc oxide + 2 mg copper) reduced progression to advanced AMD by 28% (OR 0.72, 99% CI 0.52–0.98) over 6.3 years in patients with intermediate AMD or advanced AMD in one eye.[22] AREDS2 confirmed similar results with lutein / zeaxanthin replacing beta-carotene, no difference reducing zinc from 80 mg to 25 mg.[23] A 2023 Cochrane review concluded zinc may reduce progression to late AMD (OR 0.83, 95% CI 0.70–0.98; moderate certainty).[24]

Common Cold​

A 2024 Cochrane review found zinc treatment may reduce cold duration by ~ 2.5 days (low certainty), but prophylactic zinc made little or no difference in cold incidence.[8] Adverse effects (taste aberration, GI discomfort, oral irritation) significantly more common with zinc (339 vs 254 per 1,000).[8]

Childhood Diarrhea​

WHO recommends 20 mg zinc daily for 10–14 days as adjunctive treatment for acute diarrhea in children 6–59 months. Meta-analysis found zinc shortens acute diarrhea duration by 10 hours (27 hours in malnourished children).[25]

Liver Disease and Hepatic Encephalopathy​

Zinc deficiency is present in 84–96% of cirrhotic patients and correlates inversely with Child-Pugh class (r = −0.84) and HE grade (r = −0.78).[13][26] Zinc is a cofactor for urea-cycle enzymes. The 2025 ACG guideline on malnutrition in liver disease notes zinc supplementation combined with lactulose improved number-connection tests in patients with mild HE compared with lactulose alone (meta-analysis of 4 trials, 247 patients).[13][27] A prospective RCT found 45 mg elemental zinc daily for 12 weeks significantly improved psychomotor performance and quality of life in cirrhotic patients with minimal HE.[28]

Wilson Disease​

Zinc is established treatment that works by inducing enterocyte metallothionein, which binds dietary and endogenously secreted copper and prevents absorption (creating a negative copper balance).[29] AASLD 2022 recommends zinc as first-line for asymptomatic patients and as maintenance therapy after initial chelation. Adult dosing: 150 mg elemental zinc/day in three divided doses (75 mg/day for children < 6 years).[29][30] Equally effective as D-penicillamine but much better tolerated; gastric irritation (~ 38%) is the main side effect.[29]

Wound Healing​

Zinc is required for matrix-metalloproteinase function, keratinocyte migration, collagen synthesis, and epithelial cytoprotection against oxidative stress. Oral supplementation benefits zinc-deficient patients with chronic wounds, while topical zinc (zinc-oxide paste bandages / Unna boot) promotes epithelialization and reduces superinfection even in normozincemic individuals.[7]

Toxicity and Drug Interactions​

Zinc is generally well tolerated at recommended doses; excess intake carries important risks:[16][31][32]

  • Acute toxicity (> 200 mg/day) — Nausea, vomiting, epigastric pain, lethargy, fatigue.
  • Chronic excess (100–300 mg/day) — The most clinically significant consequence is copper deficiency, which can cause sideroblastic anemia, neutropenia, and myelopathy mimicking B12 deficiency or MDS. A 2026 systematic review of 37 cases found zinc-induced copper deficiency most commonly resulted from oral supplements, denture adhesive creams, and coin ingestion, with bone marrow showing vacuolated precursors and ring sideroblasts — frequently misdiagnosed as MDS.[32]
  • Moderate excess (50–100 mg/day) — May impair immune function, decrease HDL cholesterol, interfere with iron and copper absorption.[31]
  • Drug interactions — Zinc reduces absorption of fluoroquinolones, tetracyclines, and penicillamine if taken simultaneously. When used with chelators for Wilson disease, zinc and the chelator must be separated by at least 4–5 hours.[29]

The AREDS formulation (80 mg zinc) includes 2 mg copper specifically to prevent zinc-induced copper deficiency during long-term use.[33]

Reconstructive Relevance​

1. Wound Healing — The Strongest Reconstructive Application​

Zinc cofactors matrix-metalloproteinase activity, keratinocyte migration, and collagen synthesis. Two distinct supplementation paths:

  • Oral zinc in zinc-deficient patients with chronic wounds — Strongest evidence in burns, pressure ulcers, and venous ulcers; benefit is contingent on demonstrated deficiency. Routine supplementation in normozincemic patients has not shown wound-healing benefit and risks copper deficiency.
  • Topical zinc — zinc-oxide paste bandages, Unna boot, zinc-oxide creams — Workhorses in pelvic / perineal wound care after fistula repair, vaginal-cuff dehiscence management, perineal-urethrostomy wound care, post-vulvectomy / perineal-reconstruction healing, and chronic perianal-fistula or hidradenitis-associated wounds. Promotes epithelialization and reduces superinfection even in normozincemic patients.
  • Multinutrient bundles (arginine + glutamine + vitamin C + zinc) significantly increase collagen synthesis in the early wound (Kjaer 2020 inguinal-hernia RCT — see Perioperative Nutrition).

Direct surgical-wound (urethroplasty, BMG-graft take, flap survival) evidence is weaker but mechanistically coherent. Confirm zinc status in any patient with delayed healing or persistent wound dehiscence.

2. The Copper-Deficiency Myelopathy Trap — A High-Yield Urologic Presentation​

This is the zinc finding most likely to walk into your clinic:

  • A patient on long-term zinc supplements (often self-prescribed for cold prevention, AMD prevention, or "immune support") OR a long-term denture-cream user OR (rarely) coin ingestion presents with progressive paresthesias, gait instability, and lower-tract symptoms (urgency, retention, neurogenic-bladder pattern).
  • The picture clinically mimics B12 subacute combined degeneration (posterior + lateral column demyelination). MRI may show dorsal-column signal change.
  • Workup: serum copper, ceruloplasmin, zinc, and B12.
  • If copper is low and zinc is elevated, stop the zinc source and replete copper (oral elemental copper 2–8 mg/day). Hematologic abnormalities (cytopenias, sideroblastic anemia) reverse, but neurologic recovery is often incomplete.
  • Critical pearl: always ask about zinc supplements and denture cream in any adult presenting with myeloneuropathy + new neurogenic bladder, especially when B12 is normal.

Cross-reference: Copper and Vitamin B12.

3. Cirrhotic Patients Facing Major Reconstruction​

Zinc deficiency is present in 84–96% of cirrhotics and correlates with HE grade. For the cirrhotic patient undergoing reconstruction (urinary diversion, complex prolapse, GAS), check zinc as part of the broader nutritional / hepatic workup; supplementation may improve psychomotor performance and reduce HE risk in the perioperative window. Per 2025 ACG guideline, combine with lactulose for mild HE.

4. Post-Bariatric and GLP-1 RA Populations​

Standard post-bariatric monitoring includes annual zinc screening; deficiency is common after RYGB / BPD-DS. GLP-1 RA users may have reduced dietary zinc intake from appetite suppression. Verify before any elective reconstruction in this population.

5. Pelvic / Perineal Wound-Care Practical Notes​

  • Zinc-oxide paste in fistula and perineal-wound care for diaper-dermatitis-like skin breakdown around urinary or fecal effluent.
  • Unna boot (zinc-impregnated gauze) for venous ulcers, but also adapted in perineal and lower-extremity reconstruction.
  • Stomal site care — zinc-oxide barrier creams around new stomas are standard ostomy nursing practice.

See Also​

References​

1. Imdad A, Rogner J, Sherwani RN, et al. "Zinc Supplementation for Preventing Mortality, Morbidity, and Growth Failure in Children Aged 6 Months to 12 Years." Cochrane Database of Systematic Reviews. 2023;3:CD009384. doi:10.1002/14651858.CD009384.pub3

2. Kiouri DP, Chasapis CT, Mavromoustakos T, Spiliopoulou CA, Stefanidou ME. "Zinc and Its Binding Proteins: Essential Roles and Therapeutic Potential." Archives of Toxicology. 2025;99(1):23–41. doi:10.1007/s00204-024-03891-3

3. Chasapis CT, Ntoupa PA, Spiliopoulou CA, Stefanidou ME. "Recent Aspects of the Effects of Zinc on Human Health." Archives of Toxicology. 2020;94(5):1443–1460. doi:10.1007/s00204-020-02702-9

4. Stefanache A, Lungu II, Butnariu IA, et al. "Understanding How Minerals Contribute to Optimal Immune Function." Journal of Immunology Research. 2023;2023:3355733. doi:10.1155/2023/3355733

5. Shah D, Sachdev HS, Gera T, De-Regil LM, Peña-Rosas JP. "Fortification of Staple Foods With Zinc for Improving Zinc Status and Other Health Outcomes in the General Population." Cochrane Database of Systematic Reviews. 2016;(6):CD010697. doi:10.1002/14651858.CD010697.pub2

6. Hennigar SR, Lieberman HR, Fulgoni VL, McClung JP. "Serum Zinc Concentrations in the US Population Are Related to Sex, Age, and Time of Blood Draw but Not Dietary or Supplemental Zinc." The Journal of Nutrition. 2018;148(8):1341–1351. doi:10.1093/jn/nxy105

7. Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS. "Zinc in Wound Healing: Theoretical, Experimental, and Clinical Aspects." Wound Repair and Regeneration. 2007;15(1):2–16. doi:10.1111/j.1524-475X.2006.00179.x

8. Nault D, Machingo TA, Shipper AG, et al. "Zinc for Prevention and Treatment of the Common Cold." Cochrane Database of Systematic Reviews. 2024;5:CD014914. doi:10.1002/14651858.CD014914.pub2

9. Allen LH. "Micronutrients — Assessment, Requirements, Deficiencies, and Interventions." The New England Journal of Medicine. 2025;392(10):1006–1016. doi:10.1056/NEJMra2314150

10. Gibson RS, King JC, Lowe N. "A Review of Dietary Zinc Recommendations." Food and Nutrition Bulletin. 2016;37(4):443–460. doi:10.1177/0379572116652252

11. EFSA Panel on Dietetic Products, Nutrition and Allergies. "Scientific Opinion on Dietary Reference Values for Zinc." EFSA Journal. 2014;12(10):3844. doi:10.2903/j.efsa.2014.3844

12. King JC, Brown KH, Gibson RS, et al. "Biomarkers of Nutrition for Development (BOND) — Zinc Review." The Journal of Nutrition. 2015;146(4):858S–885S. doi:10.3945/jn.115.220079

13. Singal AK, Wong RJ, Dasarathy S, et al. "ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease." The American Journal of Gastroenterology. 2025;120(5):950–972. doi:10.14309/ajg.0000000000003379

14. Wessells KR, King JC, Brown KH. "Development of a Plasma Zinc Concentration Cutoff to Identify Individuals With Severe Zinc Deficiency." The Journal of Nutrition. 2014;144(8):1204–1210. doi:10.3945/jn.114.191585

15. Berti TL, de Castro IR, Pedrosa LF, et al. "Serum Zinc Concentrations by Inflammation Status, Time of Day, and Fasting Status for Estimating Zinc Deficiency in 6–59-Mo-Old Children: ENANI-2019." The Journal of Nutrition. 2024;154(3):994–1003. doi:10.1016/j.tjnut.2024.01.004

16. Saper RB, Rash R. "Zinc: An Essential Micronutrient." American Family Physician. 2009;79(9):768–772.

17. Prasad AS. "Clinical Manifestations of Zinc Deficiency." Annual Review of Nutrition. 1985;5:341–363. doi:10.1146/annurev.nu.05.070185.002013

18. Hambidge KM. "Zinc Deficiency in Man: Its Origins and Effects." Philosophical Transactions of the Royal Society of London B. 1981;294(1071):129–144. doi:10.1098/rstb.1981.0094

19. Jassal-Prior P, Carson L, Leech S, Dubois A, Goodhead C. "The Elemental Clue: A Case Series of Acrodermatitis Enteropathica in a Tertiary Centre." The British Journal of Dermatology. 2025;193(Suppl 3):ljaf465.008. doi:10.1093/bjd/ljaf465.008

20. Axirejiang T, Simayi G, Abuduwake A, et al. "Clinical Features and Genetic Analysis of Acrodermatitis Enteropathica in an Ethnic Minority Infant From Western China: A Case Report and Literature Review." Frontiers in Medicine. 2025;12:1616196. doi:10.3389/fmed.2025.1616196

21. Foroughi E, Abtahi-Naeini B, Derakhshan M, et al. "Atypical Presentation of Acrodermatitis Enteropathica in a Child: Later Onset With Life-Threatening Severe Extensive Dermatitis and Septic Shock." BMC Pediatrics. 2025;25(1):876. doi:10.1186/s12887-025-06208-0

22. Jampol LM, Ferris FL. "Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration." JAMA. 2001. doi:10.1001/jama.286.19.2466

23. Vemulakonda GA, Bailey ST, Kim SJ, et al. "Age-Related Macular Degeneration Preferred Practice Pattern." Ophthalmology. 2025;132(4):P1–P74. doi:10.1016/j.ophtha.2024.12.018

24. Evans JR, Lawrenson JG. "Antioxidant Vitamin and Mineral Supplements for Slowing the Progression of Age-Related Macular Degeneration." Cochrane Database of Systematic Reviews. 2023;9:CD000254. doi:10.1002/14651858.CD000254.pub5

25. Shane AL, Mody RK, Crump JA, et al. "2017 IDSA Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea." Clinical Infectious Diseases. 2017;65(12):e45–e80. doi:10.1093/cid/cix669

26. Semeya AA, Elgamal R, Othman AAA. "Correlation of Serum Zinc Levels With Hepatic Encephalopathy Severity in Patients With Decompensated Liver Cirrhosis: A Prospective Observational Study From Egypt." Biological Trace Element Research. 2025. doi:10.1007/s12011-025-04544-x

27. Shen YC, Chang YH, Fang CJ, Lin YS. "Zinc Supplementation in Patients With Cirrhosis and Hepatic Encephalopathy: A Systematic Review and Meta-Analysis." Nutrition Journal. 2019;18(1):34. doi:10.1186/s12937-019-0461-3

28. Janyajirawong R, Vilaichone RK, Sethasine S. "Efficacy of Zinc Supplement in Minimal Hepatic Encephalopathy: A Prospective, Randomized Controlled Study (Zinc-MHE Trial)." Asian Pacific Journal of Cancer Prevention. 2021;22(9):2879–2887. doi:10.31557/APJCP.2021.22.9.2879

29. Schilsky ML, Roberts EA, Bronstein JM, et al. "A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 AASLD Practice Guidance." Hepatology. 2022. doi:10.1002/hep.32801

30. Food and Drug Administration. "GALZIN." Label updated 2024-04-30.

31. Fosmire GJ. "Zinc Toxicity." The American Journal of Clinical Nutrition. 1990;51(2):225–227. doi:10.1093/ajcn/51.2.225

32. Dutta A, Chaudhary V, Kumari S, et al. "Zinc-Induced Hematologic Toxicities: A Systematic Review of Descriptive Studies." Biological Trace Element Research. 2026. doi:10.1007/s12011-026-05136-z

33. Apte RS. "Age-Related Macular Degeneration." The New England Journal of Medicine. 2021;385(6):539–547. doi:10.1056/NEJMcp2102061